Asia Pacific Airway Clearance System Market, by Type, by Application, by End Use, by Country, Industry Analysis and Forecast, 2019 - 2025

The Asia Pacific Airway Clearance System Market is expected to witness market growth of 6% CAGR during the forecast period (2019-2025).

Adoption of airway clearance devices to treat cystic fibrosis, neuromuscular, bronchiectasis is expected to drive the growth of the market. These devices help with the expansion of the lung and clear the accumulation of excess mucus thereby allowing the patient to breathe properly. The use of various forms of airway clearance devices is expected to see a rise with the widespread high prevalence of cystic fibrosis.

Indoor air pollution exposure can affect the unborn child and constitute a risk factor for COPD to grow later in life. Some COPD cases originate from long-term asthma. Owing to the higher smoking rates and aging populations in many nations, COPD is expected to rise in the coming years. Most COPD cases are preventable by smoking avoidance or early cessation. It is therefore critical that countries adopt the WHO Tobacco Control Framework Convention (WHO-FCTC) and introduce the MPOWER package of measures so that non-smoking becomes the standard globally. COPD is not curable, but treatment can relieve symptoms, increase the quality of life, and reduce death risk.

Chronic obstructive pulmonary illness is a lung disease that is characterized by chronic airflow loss. COPD symptoms are slowly deteriorating and recurrent breathlessness on exertion, ultimately leading to unstable breathlessness. This tends to be diagnosed under the circumstances of relationships and can be life-threatening. The more common words for the disease were also used as labels for chronic bronchitis and emphysema.

Based on Type, the market is segmented into Positive Expiratory Pressure (PEP), Mechanical Cough Assist, High Frequency Chest Wall Oscillation (HFCWO), Oscillating PEP devices and Intrapulmonary Percussive Ventilators. Based on Application, the market is segmented into Cystic Fibrosis, Neuromuscular, Bronchiectasis, Emphysema and Other Applications. Based on End Use, the market is segmented into Home Care Settings, Ambulatory Surgical Centers, Hospitals & Clinics and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Allergan PLC, Electromed, Inc., Hill-Rom Holdings, Inc., General Physiotherapy, Inc., Thayer Medical Corporation, Vortran Medical Technology, Inc., Monaghan Medical Corporation, PARI GmbH (PARI Medical Holdings), and International Biophysics Corporation.

Scope of the Study

Market Segmentation:

By Type

• Positive Expiratory Pressure (PEP)
• Mechanical Cough Assist
• High Frequency Chest Wall Oscillation (HFCWO)
• Oscillating PEP devices and
• Intrapulmonary Percussive Ventilators

By Application

• Cystic Fibrosis
• Neuromuscular
• Bronchiectasis
• Emphysema and
• Other Applications

By End Use

• Home Care Settings
• Ambulatory Surgical Centers
• Hospitals & Clinics and
• Other End Use

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Koninklijke Philips N.V.
• Allergan PLC
• Electromed, Inc.
• Hill-Rom Holdings, Inc.
• General Physiotherapy, Inc.
• Thayer Medical Corporation
• Vortran Medical Technology, Inc
• Monaghan Medical Corporation
• PARI GmbH (PARI Medical Holdings)
• International Biophysics Corporation

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free